Woodline Partners’s 1Life Healthcare ONEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-932,950
Closed -$15.6M 917
2022
Q4
$15.6M Sell
932,950
-117,550
-11% -$1.99M 0.21% 142
2022
Q3
$18M Buy
+1,050,500
New +$16.5M 0.25% 117
2022
Q2
Sell
-252,624
Closed -$2.8M 927
2022
Q1
$2.8M Sell
252,624
-54,446
-18% -$610K 0.05% 334
2021
Q4
$5.39M Buy
307,070
+250,030
+438% +$4.85M 0.08% 275
2021
Q3
$1.16M Buy
+57,040
New +$1.47M 0.02% 500
2021
Q1
Sell
-426,394
Closed -$18.6M 490
2020
Q4
$18.6M Sell
426,394
-202,619
-32% -$6.92M 0.49% 63
2020
Q3
$17.8M Buy
629,013
+466,822
+288% +$14.7M 0.58% 47
2020
Q2
$5.89M Buy
+162,191
New +$4.57M 0.23% 102

Woodline Partners's ONEM Position: Q1 2023 in Review

Woodline Partners sold out of 1Life Healthcare (ONEM) in Q1 2023, closing a stake of 932,950 shares — an estimated $15.6M sold.

Woodline Partners first reported a position in ONEM in Q2 2020 and held it in 8 quarters. The position peaked at $18.6M in Q4 2020. 0 funds tracked by Wall St. Rank hold ONEM as of Q1 2023.

  • Woodline Partners reported no remaining 1Life Healthcare position as of Q1 2023 after selling out during the quarter.
  • Woodline Partners sold 932,950 1Life Healthcare shares in Q1 2023, an estimated $15.6M.
  • Woodline Partners first reported a position in 1Life Healthcare in Q2 2020 and held it in 8 quarters.
  • Woodline Partners's 1Life Healthcare position peaked at $18.6M in Q4 2020.
  • 0 funds tracked by Wall St. Rank held 1Life Healthcare as of Q1 2023.

Based on Woodline Partners's 13F filing for Q1 2023, filed 15 May 2023.